Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: Canada Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20071
20082
20112
20151
20165
20171
20182
20195
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Merck Sharp & Dohme LLC2
Nektar Therapeutics2
University Health Network, Toronto2
Achieve Life Sciences1
Adaptimmune1
Basilea Pharmaceutica1
Bayer1
Bioniche Life Sciences Inc.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell26
Urinary Bladder Neoplasms12
Melanoma5
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Renal Cell4
Neoplasm Metastasis4
Kidney Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Head and Neck Neoplasms2
Neoplasms2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.